To better prepare rural students for postsecondary opportunities, federal and state policymakers must increase rural access to high-quality, rigorous coursework.

Atai Life Sciences (NASDAQ: ATAI) is one of the. On June 6, analyst Michael Okunewitch of Maxim Group maintained a Buy rating on Atai Life Sciences (NASDAQ:ATAI), retaining the price target of $6.00.

In this video, Susana M. Campos, MD, MPH, discusses results from a single-arm phase 2 study of the concurrent treatment of vulvar cancer with chemoradiation and pembrolizumab.Patients who underwent ...